Intercellular adhesion molecules and their binding ligands
CA 1341185 C · Owner: Dana Farber Cancer Institute · Inventors: Dustin, Michael Loran; Marlin, Steven Dean; Rothlein, Robert
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to intercellular adhesion molecules such as ICAM-1 which are involved in the process through which populations of lymphocytes recognize and adhere to cellular substrates so that they may migrate to sites of inflammation and interact with cells during inflammatory reactions. The present invention additionally relates to ligand molecules capable of binding to such intercellular adhesion molecules to a screening, assay for these ligands and to uses for the intercellular , adhesion molecule the ligand molecules, and the screening assay.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted February 20, 2001. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended February 20, 2018.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.